Saturday 17 October 2026
Export WINT’s income statement to Excel — free account
Windtree Therapeutics, Inc.
WINT Healthcare Biotechnology
In the quarter to September 2025, EPS grew 99.5% and free cash flow grew 1.12%, each against the same quarter a year earlier.
0.00
0.00
NaN
Follow WINT
| Older periods | Dec '24 | Mar '25 | Jun '25 | Sep '25 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(81.98%) | (161.40%) | (666.00%) | 1,356.23% | |
| (18.20%) | (72.97%) | (78.12%) | (210.34%) | ||
ROIC |
(178.02%) | (167.12%) | (103.49%) | (386.34%) | |
Return on Tangible Assets |
180.97% | 433.35% | 266.88% | 333.66% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(293.04) | (13.65) | (3.11) | (0.57) | |
Free Cash Flow |
(15.41) | (14.86) | (15.19) | (15.12) | |
Capital Expenditures |
(0.01) | — | — | — | |
| Other line items | |||||
Cash ROIC |
(121.04%) | (123.81%) | (129.99%) | (259.50%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | (0.08) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(111.23) | (106.71) | (87.00) | (68.64) | |
Operating CF/Net income |
2.81 | 0.72 | 0.64 | 0.31 | |
Depreciation/Fixed assets |
1.63 | 1.88 | 1.43 | 9.87 | |
Capex/Depreciation |
(0.07) | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(292.81) | (13.65) | (3.11) | (0.57) | |
Capex per Share |
(0.23) | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | — | — | — |
Columns are period end dates